These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28923245)
1. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role. Lapid D; Lahav-Baratz S; Cohen S Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245 [TBL] [Abstract][Full Text] [Related]
2. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha. Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105. Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495 [TBL] [Abstract][Full Text] [Related]
4. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655 [TBL] [Abstract][Full Text] [Related]
5. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC. Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064 [TBL] [Abstract][Full Text] [Related]
6. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth. Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612 [TBL] [Abstract][Full Text] [Related]
7. ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor. Cohen S; Ciechanover A; Kravtsova-Ivantsiv Y; Lapid D; Lahav-Baratz S Biochem Biophys Res Commun; 2009 Nov; 389(2):205-10. PubMed ID: 19695220 [TBL] [Abstract][Full Text] [Related]
8. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain. Cohen S; Orian A; Ciechanover A J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967 [TBL] [Abstract][Full Text] [Related]
9. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation. Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748 [TBL] [Abstract][Full Text] [Related]
10. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing. Cohen S; Achbert-Weiner H; Ciechanover A Mol Cell Biol; 2004 Jan; 24(1):475-86. PubMed ID: 14673179 [TBL] [Abstract][Full Text] [Related]
11. The NEDD8 pathway is essential for SCF(beta -TrCP)-mediated ubiquitination and processing of the NF-kappa B precursor p105. Amir RE; Iwai K; Ciechanover A J Biol Chem; 2002 Jun; 277(26):23253-9. PubMed ID: 11953428 [TBL] [Abstract][Full Text] [Related]
12. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis. Cohen S; Lahav-Baratz S; Ciechanover A Biochem Biophys Res Commun; 2006 Jun; 345(1):7-13. PubMed ID: 16678126 [TBL] [Abstract][Full Text] [Related]
13. SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase. Orian A; Gonen H; Bercovich B; Fajerman I; Eytan E; Israël A; Mercurio F; Iwai K; Schwartz AL; Ciechanover A EMBO J; 2000 Jun; 19(11):2580-91. PubMed ID: 10835356 [TBL] [Abstract][Full Text] [Related]
14. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Belich MP; Salmerón A; Johnston LH; Ley SC Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Loniewski KJ; Patial S; Parameswaran N Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094 [TBL] [Abstract][Full Text] [Related]
16. betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Lang V; Janzen J; Fischer GZ; Soneji Y; Beinke S; Salmeron A; Allen H; Hay RT; Ben-Neriah Y; Ley SC Mol Cell Biol; 2003 Jan; 23(1):402-13. PubMed ID: 12482991 [TBL] [Abstract][Full Text] [Related]
17. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor. Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910 [TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression. Kravtsova-Ivantsiv Y; Ciechanover A Mol Cell Oncol; 2015; 2(4):e1054552. PubMed ID: 27308511 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Karin M; Ben-Neriah Y Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071 [TBL] [Abstract][Full Text] [Related]
20. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]